Clinical Trial Update: OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of OGX-011 with docetaxel in locally advanced or metastatic breast cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• OGX-011 (custirsen)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED